Meropenem to Treat Valproic Acid Intoxication.

Area of Science:

• Pharmacology
• Clinical Toxicology

Background:

• Therapeutic drug monitoring (TDM) is crucial for managing medications with narrow therapeutic indices.
• Valproic acid (VPA) intoxication can lead to severe toxicity, necessitating effective management strategies.

Purpose of the Study:

• To describe a case of severe valproic acid intoxication.
• To evaluate the efficacy of meropenem in enhancing valproic acid clearance.

Main Methods:

• A patient with documented severe valproic acid intoxication was treated.
• Meropenem was administered off-label to facilitate VPA clearance.
• Valproic acid levels were monitored before and after treatment.

Main Results:

• The patient presented with critically high total valproic acid (844 mg/L) and unbound valproic acid (604 mg/L) levels.
• Following meropenem administration, valproic acid levels significantly decreased within 24 hours.
• The observed reduction supports the hypothesized carbapenem-VPA drug interaction.

Conclusions:

• Off-label meropenem administration can be an effective strategy for enhancing valproic acid clearance in cases of severe intoxication.
• This approach leverages the known drug-drug interaction between carbapenems and valproic acid.
• Further research may explore this intervention in clinical settings for managing valproic acid toxicity.